| Authors: |
Iveson T; University of Southampton, Southampton, United Kingdom., Saunders MP; The Christie Hospital, Manchester, United Kingdom., Kelly C; Glasgow Oncology Clinical Trials Unit, School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Kerr RS; Department of Oncology, University of Oxford, Oxford, United Kingdom., Cassidy J; Glasgow Oncology Clinical Trials Unit, School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Hollander NH; Department of Oncology and Palliative Care, Zealand University Hospital, Naestved, Denmark., Tabernero J; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, IOB-Quiron, CIBERONC, Barcelona, Spain., Haydon A; Australasian Gastro-Intestinal Trials Group (AGITG), Alfred Hospital, Melbourne, Australia., Glimelius B; Department of Immunology, Genetics and Pathology, University of Uppsala, Uppsala, Sweden., Harkin A; Glasgow Oncology Clinical Trials Unit, School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Allan K; Glasgow Oncology Clinical Trials Unit, School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., McQueen J; Glasgow Oncology Clinical Trials Unit, School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Pearson S; OCTO, Department of Oncology, University of Oxford, Oxford, United Kingdom., Boyd KA; Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom., Briggs AH; Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom., Waterston A; Beatson West of Scotland Cancer Centre, NHS GGC HB, Glasgow, United Kingdom., Medley L; Royal United Hospital, Bath, United Kingdom., Ellis R; Royal Cornwall Hospitals NHS Trust, Cornwall, United Kingdom., Dhadda AS; Castle Hill Hospital, Hull, United Kingdom., Harrison M; Mount Vernon Cancer Centre, Northwood, United Kingdom., Falk S; Bristol Cancer Institute, Bristol, United Kingdom., Rees C; Southampton University Hospital NHS Foundation Trust, Southampton, United Kingdom., Olesen RK; Department of Oncology, Aarhus University Hospital, Aarhus C, Denmark., Propper D; Barts Cancer Institute, Queen Mary, University of London, London, United Kingdom., Bridgewater J; University College London, London, United Kingdom (part funded by the UCLH/UCL Biomedical Research Centre)., Azzabi A; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom., Cunningham D; Royal Marsden, London, United Kingdom (funded by NIHR BRC at the Royal Marsden)., Hickish T; University Hospitals Dorset/Bournemouth University, Bournemouth, United Kingdom., Gollins S; North Wales Cancer Treatment Centre, Rhyl, United Kingdom., Wasan HS; Hammersmith Hospital, Imperial College London, London, United Kingdom., Church D; Department of Oncology, University of Oxford, Oxford, United Kingdom., Domingo E; Department of Oncology, University of Oxford, Oxford, United Kingdom. |
